文献速递重症综合管理与镇静镇痛儿科与产科急症

需要持续肾脏替代治疗的脓毒症儿童及年轻成人的特征与结局:WE-ROCK 国际多中心比较分析

Characteristics and Outcomes of Children and Young Adults With Sepsis Requiring Continuous Renal Replacement Therapy: A Comparative Analysis From the Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK).
PubMed 文献 · Crit Care Med · 2024-09-11
一句话结论脓毒症儿童启动CRRT后28天脱机率更低(30% vs 38%)、MAKE-90更高(70% vs 61%)、死亡率更高(47% vs 31%),且血管活性药使用每延长1天与MAKE-90及死亡风险独立相关。

该研究为WE-ROCK国际多中心回顾性研究的二次分析,纳入2015年1月1日至2021年12月31日九国34个中心0-25岁因AKI和/或液体过负荷接受CRRT的1016例患者,其中446例(44%)在CRRT启动时合并脓毒症。脓毒症组28天脱离CRRT比例低于非脓毒症组(30% vs 38%,p<0.001),MAKE-90(70% vs 61%,p=0.002)和死亡率(47% vs 31%,p<0.001)更高,但脓毒症存活者90天RRT依赖比例更低(10% vs 18%,p=0.011)。多变量回归显示CRRT前血管活性药需求、达到负液体平衡时间及CRRT第一周中位每日液体平衡与MAKE-90无关,而血管活性药支持每延长1天与MAKE-90(aOR 1.16,95%CI 1.05-1.28)和死亡(aOR 1.20,95%CI 1.1-1.32)风险增加独立相关。

要点

  • 脓毒症儿童启动CRRT后28天脱机率低于非脓毒症患儿(30% vs 38%,p<0.001),MAKE-90更高(70% vs 61%,p=0.002),死亡率更高(47% vs 31%,p<0.001)。
  • 脓毒症存活者90天RRT依赖比例低于非脓毒症存活者(10% vs 18%,p=0.011)。
  • CRRT第一周血管活性药支持每延长1天,MAKE-90风险增加(aOR 1.16,95%CI 1.05-1.28),死亡风险增加(aOR 1.20,95%CI 1.1-1.32)。
  • CRRT前血管活性药需求、达到负液体平衡时间及CRRT第一周中位每日液体平衡与MAKE-90无关。

适用人群与场景

  • 0-25岁因急性肾损伤(AKI)和/或液体过负荷接受持续肾脏替代治疗(CRRT)的患者。
  • 来自九国34个中心的新生儿、心脏及儿科重症监护病房(PICU),时间为2015年1月1日至2021年12月31日。
  • 其中446例(44%)在CRRT启动时合并脓毒症。

研究设计与关键结果

  • 研究类型:国际多中心回顾性研究(WE-ROCK)的二次分析,共纳入1016例患者,其中446例(44%)在CRRT启动时合并脓毒症。
  • 主要复合终点MAKE-90(定义:CRRT启动后90天内死亡、肾脏替代治疗依赖或估算肾小球滤过率较基线下降>25%的复合终点)总发生率为650例(64%)。
  • 脓毒症组与非脓毒症组比较:28天脱离CRRT比例30% vs 38%(p<0.001);MAKE-90发生率70% vs 61%(p=0.002);死亡率47% vs 31%(p<0.001);脓毒症存活者90天RRT依赖比例10% vs 18%(p=0.011)。
  • 多变量回归:CRRT前血管活性药需求、达到负液体平衡时间及CRRT第一周中位每日液体平衡与MAKE-90无关联;血管活性药支持每延长1天,MAKE-90的调整OR为1.16(95%CI 1.05-1.28),死亡的调整OR为1.20(95%CI 1.1-1.32)。

证据类型、等级与局限

  • 证据类型:国际多中心回顾性研究的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 脓毒症患儿启动CRRT时,临床医生应认识到其28天脱机率更低、MAKE-90和死亡率更高,需加强监护与预后沟通。
  • CRRT第一周血管活性药支持时间延长与MAKE-90及死亡风险增加独立相关,作者认为这可能是潜在透析损伤(dialytrauma)的替代指标,提示关注血管活性药使用时长。
  • 脓毒症存活者90天RRT依赖比例低于非脓毒症存活者,随访中可据此评估肾脏恢复预期。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Pediatric sepsis-associated acute kidney injury (AKI) often requires continuous renal replacement therapy (CRRT), but limited data exist regarding patient characteristics and outcomes. We aimed to describe these features, including the impact of possible dialytrauma (i.e., vasoactive requirement, negative fluid balance) on outcomes, and contrast them to nonseptic patients in an international cohort of children and young adults receiving CRRT.

DESIGN: A secondary analysis of Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK), an international, multicenter, retrospective study.

SETTING: Neonatal, cardiac and PICUs at 34 centers in nine countries from January 1, 2015, to December 31, 2021.

PATIENTS: Patients 0-25 years old requiring CRRT for AKI and/or fluid overload.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Among 1016 patients, 446 (44%) had sepsis at CRRT initiation and 650 (64%) experienced Major Adverse Kidney Events at 90 days (MAKE-90) (defined as a composite of death, renal replacement therapy [RRT] dependence, or > 25% decline in estimated glomerular filtration rate from baseline at 90 d from CRRT initiation). Septic patients were less likely to liberate from CRRT by 28 days (30% vs. 38%; p < 0.001) and had higher rates of MAKE-90 (70% vs. 61%; p = 0.002) and higher mortality (47% vs. 31%; p < 0.001) than nonseptic patients; however, septic survivors were less likely to be RRT dependent at 90 days (10% vs. 18%; p = 0.011). On multivariable regression, pre-CRRT vasoactive requirement, time to negative fluid balance, and median daily fluid balance over the first week of CRRT were not associated with MAKE-90; however, increasing duration of vasoactive requirement was independently associated with increased odds of MAKE-90 (adjusted OR [aOR], 1.16; 95% CI, 1.05-1.28) and mortality (aOR, 1.20; 95% CI, 1.1-1.32) for each additional day of support.

CONCLUSIONS: Septic children requiring CRRT have different clinical characteristics and outcomes compared with those without sepsis, including higher rates of mortality and MAKE-90. Increasing duration of vasoactive support during the first week of CRRT, a surrogate of potential dialytrauma, appears to be associated with these outcomes.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Stanski NL, Gist KM, Hasson D, et al. Characteristics and Outcomes of Children and Young Adults With Sepsis Requiring Continuous Renal Replacement Therapy: A Comparative Analysis From the Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK). Crit Care Med. 2024. PMID: 39258974. doi:10.1097/CCM.0000000000006405

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。